| 摘要: |
| 糖基化是由糖基转移酶调控的产生糖与其他糖、蛋白质或脂类的糖苷连接的酶促过程,是各种生物过程的基础。异常糖基化是许多癌症的共同特征,在肿瘤的发生发展中起着至关重要的作用,是抗肿瘤研究的重要靶标。本文首先对糖基化、糖基转移酶和肿瘤相关糖类抗原进行简单介绍,主要针对糖基化过程进行抗肿瘤药物开发的研究现状进行了综述和展望。 |
| 关键词: 糖基化 抗肿瘤药物 糖基转移酶 肿瘤相关糖类抗原 |
| DOI:10.13506/j.cnki.jpr.2023.10.012 |
| 基金项目:国家自然科学基金(No.82002971) |
|
|
|
| Research progress on the development of antitumor drugs targeting glycosylation |
| TIAN Lulu,DAI Peiying |
| (Institute of Pharmaceutical Sciences,China Pharmaceutical University,Nanjing 211198,China) |
| Abstract: |
| Catalyzed by glycosyltransferases, glycosylation is an enzymatic process that produces either saccharides or glycosidic linkages to saccharides, proteins or lipids, and is the basis of various biological processes. Aberrant glycosylation, playing crucial roles in tumor development, is a common feature of many cancers, which makes it an important target in the anti-tumor research. In this review, we first briefly introduce glycosylation, glycosyltransferases and the tumor-associated carbohydrate antigens, and mainly summarize the most recent information about the research progress on the development of antitumor drugs targeting glycosylation. |
| Key words: Glycosylation Antitumor drugs Glycosyltransferase TACAs |